Mankin H - Search Results

1

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.

Susa M, Iyer AK, Ryu K, Hornicek FJ, Mankin H, Amiji MM, Duan Z. Susa M, et al. Among authors: mankin h. BMC Cancer. 2009 Nov 16;9:399. doi: 10.1186/1471-2407-9-399. BMC Cancer. 2009. PMID: 19917123 Free PMC article.

2

CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.

Duan Z, Ames RY, Ryan M, Hornicek FJ, Mankin H, Seiden MV. Duan Z, et al. Among authors: mankin h. Cancer Chemother Pharmacol. 2009 Mar;63(4):681-9. doi: 10.1007/s00280-008-0785-8. Epub 2008 Jun 28. Cancer Chemother Pharmacol. 2009. PMID: 18587580 Free PMC article.

3

Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression.

Yang C, Yang S, Wood KB, Hornicek FJ, Schwab JH, Fondren G, Mankin H, Duan Z. Yang C, et al. Among authors: mankin h. Apoptosis. 2009 Jan;14(1):124-33. doi: 10.1007/s10495-008-0282-x. Apoptosis. 2009. PMID: 19052873

4

RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.

Yang C, Hornicek FJ, Wood KB, Schwab JH, Mankin H, Duan Z. Yang C, et al. Among authors: mankin h. Cancer Chemother Pharmacol. 2009 Aug;64(3):607-14. doi: 10.1007/s00280-008-0912-6. Epub 2009 Jan 6. Cancer Chemother Pharmacol. 2009. PMID: 19125251

5

Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.

Duan Z, Choy E, Harmon D, Yang C, Ryu K, Schwab J, Mankin H, Hornicek FJ. Duan Z, et al. Among authors: mankin h. Mol Cancer Ther. 2009 Aug;8(8):2122-30. doi: 10.1158/1535-7163.MCT-09-0115. Epub 2009 Jul 28. Mol Cancer Ther. 2009. PMID: 19638450 Free PMC article.

6

Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis.

Ryu K, Choy E, Yang C, Susa M, Hornicek FJ, Mankin H, Duan Z. Ryu K, et al. Among authors: mankin h. J Orthop Res. 2010 Jul;28(7):971-8. doi: 10.1002/jor.21088. J Orthop Res. 2010. PMID: 20063378 Free article.

7

Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma.

Duan Z, Ji D, Weinstein EJ, Liu X, Susa M, Choy E, Yang C, Mankin H, Hornicek FJ. Duan Z, et al. Among authors: mankin h. Cancer Lett. 2010 Jul 28;293(2):220-9. doi: 10.1016/j.canlet.2010.01.014. Epub 2010 Feb 9. Cancer Lett. 2010. PMID: 20144850

8

Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells.

Yang C, Choy E, Hornicek FJ, Wood KB, Schwab JH, Liu X, Mankin H, Duan Z. Yang C, et al. Among authors: mankin h. Cancer Chemother Pharmacol. 2011 Feb;67(2):439-46. doi: 10.1007/s00280-010-1344-7. Epub 2010 May 12. Cancer Chemother Pharmacol. 2011. PMID: 20461381

9

Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.

Susa M, Iyer AK, Ryu K, Choy E, Hornicek FJ, Mankin H, Milane L, Amiji MM, Duan Z. Susa M, et al. Among authors: mankin h. PLoS One. 2010 May 24;5(5):e10764. doi: 10.1371/journal.pone.0010764. PLoS One. 2010. PMID: 20520719 Free PMC article.

10

Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer.

Guo Y, Nemeth J, O'Brien C, Susa M, Liu X, Zhang Z, Choy E, Mankin H, Hornicek F, Duan Z. Guo Y, et al. Among authors: mankin h. Clin Cancer Res. 2010 Dec 1;16(23):5759-69. doi: 10.1158/1078-0432.CCR-10-1095. Epub 2010 Aug 10. Clin Cancer Res. 2010. PMID: 20699329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

551 results

Search Page

Filters